Immunogenicity, Safety, and Reactogenicity of Combined Reduced-Antigen-content Diphtheria-Tetanus-acellular Pertussis Vaccine Administered As a Booster Vaccine Dose in Healthy Russian Participants: a Phase III, Open-Label Study.
Human vaccines & immunotherapeutics（2020）
Key words
Acellular pertussis,diphtheria,tetanus,booster vaccination,immunogenicity,reactogenicity,safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined